For research use only
| Cat No. | ABC-TC0892 |
| Product Type | Human Leukemia Cell Lines |
| Cell Type | Lymphocyte-like |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Product Code | P30-OHK; P30 OHK; P30OHK; P30/Ohkubo; P30/OHKUBO; P30-OHKUBO; P30/0HK |
The P30/OHK cell line provides a hematopoietic model for immunology research, tumor progression studies, and therapeutic target investigation.
CD2-, CD5-, CD19+, CD20-(revised to be negative at 2009/1/22), CD8+/-, Ia+, J5+, TdT+, PAS+, acid phosphatase+, having pre B characteristics. Non T non B acute lymphoblastic leukemia (ALL).
| Product Code | P30-OHK; P30 OHK; P30OHK; P30/Ohkubo; P30/OHKUBO; P30-OHKUBO; P30/0HK |
| Species | Human |
| Cat.No | ABC-TC0892 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocyte-like |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Leukemia Cell Lines |
For research use only
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
The percentage of CD19 expression in P30/OHK Cell Line was detected by flow cytometry to be approximately 76.2%.
The percentage of CD33 expression in P30/OHK Cell Line was detected by flow cytometry to be approximately 58.4%.
